Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry

(Formerly 'Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents')

ISSN: 1871-5222 - Volume 8, 4 Issues, 2008

Editor-in-Chief:

Paul J. Davis
Ordway Research Institute, Inc.
150 New Scotland Avenue
Albany, NY 12208
USA
Tel: 518-641-6410
Fax: 518-641-6303
E-mail: PDavis@ordwayresearch.org

Associate Editors:

B.M. Forman (Diabetes Research Center, RoadDuarte, CA, USA)
E.J. Schaefer (New England Medical Center, Boston, MA, USA)
T.M. Willson (GlaxoSmithKline, USA)

Editorial Advisory Board:

A. Allera (University of Bonn, Bonn, Germany)
C. Arbbeny (GelTex Pharmaceuticals, Waitham, MA, USA)
C.E. Augelli Szafran (Ann Arbor Laboratories, Ann Arbor, MI, USA)
P.M. Aviram (Rambam Medical Center, Haifa, Isreal)
L.P. Braxton (Corgentech Inc., Palo Alto, CA, USA)
M.R. Briggs (Pharmacia Corporation, St. Louis, MO, USA)
G.A. Camejo (AstraZeneca R&D, Molndal, Sweden)
H.H. Dong (University of Pittsburgh, Pittsburgh, PA, USA)
M.R. Emmerling (Pfizer Global Research & Development, Ann Arbor, MI, USA)
W.G. Foster (McMaster University, Hamilton, Canada)
M. Heiman (Lilly Corporate Center, Indianapolis, IN, USA)
L. Iuliano (La Sapienza University, Latina, Italy)
T. Iwasaki (Hyogo College of Medicine, Hyogo, Japan)
E. Jeung (Chungbuk National University, Chungbuk, South Korea)
E. Karnieli (Rambam Medical Center, Haifa, Israel)
M. Khan (University of Warwick, Coventry, UK)
M.L. Koschinsky (Queen's University, Kingston, USA)
K.F. Kozarsky (GlaxoSmithKline Company, King of Prussia, PA, USA)
B.R. Krause (Pfizer Global Research And Development, Ann Arbor, MI, USA)
T. Leff (Wayne state University, Detroit, MI, USA)
S.P. Little (Eli Lilly and Company, Indianapolis, IN, USA)
A. Mari (Institute of Biomedical Engineering, Padova, Italy)
D.F. Mierke (Brown University, Providence, RI, USA)
M. Moreno (University of Sannio, Benevento, Italy)
R. Morishita (Osaka University, Suita, Japan)
G. Muller (Sanofi-Aventis Pharma, Frankfurt, Germany)
E.J. Niesor (F.Hoffmann-La Roche Ltd., Basel, Switzerland)
U.S. Ryan (Reddy US Therapeutics Inc., Norcross, GA, USA)
C.S. Samuel (University of Melbourne, Parkville, Australia)
U. Saxena (Dr.Reddy's Laboratories, Norcross, GA, USA)
D.R. Sliskovic (Pfizer Global Research, Ann Arbor, MI, USA)
A. Srivastava ( Bristol-Myers Squibb Company, Pennington, NJ, USA)
D. Sviridov (Baker Heart Research Institute, Melbourne, Australia)
H. Tilg (Christian Doppler Research Laboratory, Hall in Tyrol, Austria)
M.R. Uskokovic (Hoffmann La Roche Inc., Nutley, New Jersey, USA)
M.R. Wick (University of Virginia, Charlottesville, VA, USA)